Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,541 to 1,560 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Multiplex and Colorimetric Reverse Transcription Loop-Mediated Isothermal Amplification Assay for Sensitive and Rapid Detection of Novel SARS-CoV-2. | Front Cell Infect Microbiol | 2021 | 34268131 | PubTator, text mining | PubMed |
| Meta-Analysis and Structural Dynamics of the Emergence of Genetic Variants of SARS-CoV-2. | Front Microbiol | 2021 | 34267735 | PubTator, text mining | PubMed |
| Naturally Occurring Bioactives as Antivirals: Emphasis on Coronavirus Infection. | Front Pharmacol | 2021 | 34267652 | PubTator, text mining | PubMed |
| Novel Highly Divergent SARS-CoV-2 Lineage With the Spike Substitutions L249S and E484K. | Front Med (Lausanne) | 2021 | 34262921 | PubTator, text mining | PubMed |
| An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19. | Biomed Res Int | 2021 | 34258282 | PubTator, text mining | PubMed |
| Potent SARS-CoV-2 mRNA Cap Methyltransferase Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate. | ACS Med Chem Lett | 2021 | 34257831 | PubTator, text mining | PubMed |
| Time to 'Mind the Gap' in novel small molecule drug discovery for direct-acting antivirals for SARS-CoV-2. | Curr Opin Virol | 2021 | 34256351 | PubTator, text mining | PubMed |
| Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh. | Virus Genes | 2021 | 34251592 | PubTator, text mining | PubMed |
| Porcine enteric coronaviruses: an updated overview of the pathogenesis, prevalence, and diagnosis. | Vet Res Commun | 2021 | 34251560 | PubTator, text mining | PubMed |
| Peptide inhibitors against SARS-CoV-2 2'-O-methyltransferase involved in RNA capping: A computational approach. | Biochem Biophys Rep | 2021 | 34250275 | PubTator, text mining | PubMed |
| Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease. | Front Chem | 2021 | 34249864 | PubTator, text mining | PubMed |
| Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis. | Front Cell Neurosci | 2021 | 34248502 | PubTator, text mining | PubMed |
| High-throughput analysis of the interactions between viral proteins and host cell RNAs. | Comput Biol Med | 2021 | 34246161 | PubTator, text mining | PubMed |
| Acute Infection of Viral Pathogens and Their Innate Immune Escape. | Front Microbiol | 2021 | 34239508 | PubTator, text mining | PubMed |
| In silico analysis of the aggregation propensity of the SARS-CoV-2 proteome: Insight into possible cellular pathologies. | Biochim Biophys Acta Proteins Proteom | 2021 | 34237472 | PubTator, text mining | PubMed |
| Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2. | Int J Biol Macromol | 2021 | 34237371 | PubTator, text mining | PubMed |
| Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis. | EMBO J | 2021 | 34232536 | PubTator, text mining | PubMed |
| Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins. | Orphanet J Rare Dis | 2021 | 34229750 | PubTator, text mining | PubMed |
| SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium. | Immunol Lett | 2021 | 34228987 | PubTator, text mining | PubMed |
| Two Inhibitors Against the 3C-Like Proteases of Swine Coronavirus and Feline Coronavirus. | Virol Sin | 2021 | 34228261 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=78